Prices are updated after-hours


Sort by: gain open | gain high | gain close | publishing date

symbols : NOVN    save search

Novan Announces Presentation of Two Posters at the 2022 Winter Clinical Dermatology Conference
Published: 2022-01-14 (Crawled : 14:30) - globenewswire.com
NOVN | $3.11 | twitter stocktwits trandingview |
Health Technology
| | O: 0.53% H: 0.0% C: 0.0%

ces conference presentation
Novan to Participate in the Virtual Investor Roundtable Event
Published: 2021-11-12 (Crawled : 14:00) - globenewswire.com
NOVN | $3.11 | twitter stocktwits trandingview |
Health Technology
| | O: -0.9% H: 0.0% C: 0.0%


Novan Provides Corporate Update and Reports Third Quarter 2021 Financial Results
Published: 2021-11-10 (Crawled : 11:00) - globenewswire.com
NOVN | $3.11 | twitter stocktwits trandingview |
Health Technology
| | O: 3.9% H: 2.27% C: -6.52%
SYNH | $86.24 | twitter stocktwits trandingview |
Health Services
| | O: -1.13% H: 1.52% C: -0.05%

financial results results
Novan Announces Favorable Preclinical Safety Data and Intent to Advance SB019 for Treatment of COVID-19
Published: 2021-11-09 (Crawled : 14:00) - globenewswire.com
NOVN | $3.11 | twitter stocktwits trandingview |
Health Technology
| | O: -2.23% H: 0.0% C: 0.0%

covid treatment preclinical
Novan Announces Fireside Chat Hosted by Jonathan Aschoff, Ph.D. of ROTH Capital Partners
Published: 2021-11-04 (Crawled : 13:00) - globenewswire.com
NOVN | $3.11 | twitter stocktwits trandingview |
Health Technology
| | O: 1.44% H: 5.26% C: 2.7%


Novan to Report Third Quarter 2021 Financial Results on November 10, 2021Company to host conference call and webcast on Wednesday, November 10, 2021, at 8:30 a.m. ET
Published: 2021-11-03 (Crawled : 20:00) - biospace.com/
NOVN | $3.11 | twitter stocktwits trandingview |
Health Technology
| | O: -0.86% H: 0.0% C: 0.0%

financial results results conference
Novan to Report Third Quarter 2021 Financial Results on November 10, 2021
Published: 2021-11-03 (Crawled : 14:00) - globenewswire.com
NOVN | $3.11 | twitter stocktwits trandingview |
Health Technology
| | O: -0.86% H: 0.0% C: 0.0%

financial results results
Novan Appoints Brian M. Johnson as Chief Commercial Officer and Receives Conditional FDA Acceptance of Proposed Brand Name KINSOLUS™ for SB206 in Molluscum Contagiosum
Published: 2021-11-02 (Crawled : 13:00) - globenewswire.com
NOVN | $3.11 | twitter stocktwits trandingview |
Health Technology
| | O: 3.7% H: 1.0% C: -0.14%

molluscum fda fda acceptance
Novan Reports Safety Data from B-SIMPLE4 Pivotal Phase 3 Study of SB206
Published: 2021-09-23 (Crawled : 12:00) - globenewswire.com
NOVN | $3.11 | twitter stocktwits trandingview |
Health Technology
| | O: -0.24% H: 2.39% C: 0.95%

phase 3
Novan to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference– Live fireside chat with Paula Brown Stafford, President and Chief Executive Officer of Novan on Tuesday, September 28 at 8:00 AM ET –
Published: 2021-09-20 (Crawled : 20:00) - biospace.com/
NOVN | $3.11 | twitter stocktwits trandingview |
Health Technology
| | O: -4.21% H: 1.59% C: 0.61%

ford conference
Novan to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference
Published: 2021-09-20 (Crawled : 13:15) - globenewswire.com
NOVN | $3.11 | twitter stocktwits trandingview |
Health Technology
| | O: -4.21% H: 1.59% C: 0.61%

conference
Novan Announces Strategic Priorities and Outlines Key Milestones
Published: 2021-09-09 (Crawled : 13:00) - globenewswire.com
NOVN | $3.11 | twitter stocktwits trandingview |
Health Technology
| | O: -6.59% H: 0.0% C: -4.42%
SYNH | $86.24 | twitter stocktwits trandingview |
Health Services
| | O: 0.17% H: 0.91% C: -0.21%


Novan Engages Syneos Health as Commercial Solutions Provider for SB206
Published: 2021-09-08 (Crawled : 14:00) - globenewswire.com
NOVN | $3.11 | twitter stocktwits trandingview |
Health Technology
| | O: 0.31% H: 5.89% C: 3.56%
SYNH | $86.24 | twitter stocktwits trandingview |
Health Services
| | O: 0.19% H: 0.0% C: -0.93%


Powerful Software Plays a key Role in Keeping the Pandemic at Bay
Published: 2021-09-08 (Crawled : 13:15) - prnewswire.com
CEMI | $0.93 | twitter stocktwits trandingview |
Health Technology
| | O: -0.38% H: 1.72% C: -0.38%
TRVN | $0.518 | twitter stocktwits trandingview |
Health Technology
| | O: 1.55% H: 0.61% C: -5.34%
NOVN | $3.11 | twitter stocktwits trandingview |
Health Technology
| | O: 0.31% H: 5.89% C: 3.56%

software
Novan to Present at H.C. Wainwright 23rd Annual Global Investment Conference
Published: 2021-09-07 (Crawled : 13:00) - globenewswire.com
NOVN | $3.11 | twitter stocktwits trandingview |
Health Technology
| | O: -0.2% H: 3.94% C: -1.11%

conference
Novan to Host Corporate Update Conference Call and Webcast on September 9, 2021
Published: 2021-09-02 (Crawled : 13:15) - globenewswire.com
NOVN | $3.11 | twitter stocktwits trandingview |
Health Technology
| | O: 0.21% H: 5.32% C: 2.61%

conference
Novan Appoints Tomoko Maeda-Chubachi, MD, PhD, MBA as Chief Medical Officer
Published: 2021-08-24 (Crawled : 13:00) - globenewswire.com
LLY | News | $247.43 | twitter stocktwits trandingview |
Health Technology
| | O: -0.6% H: 0.47% C: -1.29%
NOVN | $3.11 | twitter stocktwits trandingview |
Health Technology
| | O: 2.16% H: 2.65% C: 2.12%
PFE | $52.79 | twitter stocktwits trandingview |
Health Technology
| | O: -0.38% H: 0.62% C: -2.73%


Novan Reports Second Quarter 2021 Financial Results and Provides Corporate Update
Published: 2021-08-12 (Crawled : 12:00) - globenewswire.com
NOVN | $3.11 | twitter stocktwits trandingview |
Health Technology
| | O: -1.56% H: 28.55% C: 17.25%

financial results results
Novan to Report Second Quarter 2021 Financial Results on August 12, 2021
Published: 2021-08-05 (Crawled : 12:15) - globenewswire.com
NOVN | $3.11 | twitter stocktwits trandingview |
Health Technology
| | O: 0.63% H: 4.72% C: 4.22%

financial results results
Novan Announces Last Patient Visit at Week 24 in B-SIMPLE4 Pivotal Phase 3 Trial of SB206 in Patients with Molluscum Contagiosum
Published: 2021-07-28 (Crawled : 12:15) - globenewswire.com
NOVN | $3.11 | twitter stocktwits trandingview |
Health Technology
| | O: 1.49% H: 2.45% C: -1.47%

molluscum phase 3 trial
Your saved searches


Save your searches and get alerts when important news are released.

Mentioned Today
COTY | News | $8.79 | twitter stocktwits trandingview |
Consumer Non-Durables

DXR | News | $11.075 | twitter stocktwits trandingview |
Health Technology

FCFS | News | $70.6 | twitter stocktwits trandingview |
Finance

INCY | News | $74.95 | twitter stocktwits trandingview |
Health Technology

KRP | News | $14.56 | twitter stocktwits trandingview |
Miscellaneous

LLY | News | $247.43 | twitter stocktwits trandingview |
Health Technology

OVLY | News | $17.5101 | twitter stocktwits trandingview |
Finance